DEPDC5 and gastrointestinal stromal tumor: Chromosome 22q deletions are observed in ~50% of GIST and recurrent genomic inactivation of DEPDC5 (>16%) makes it the bona-fide tumor suppressor contributing to GIST progression via increased mTORC1 pathway signaling [210].